zoledronic acid has been researched along with Aging in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 11 (78.57) | 24.3611 |
2020's | 2 (14.29) | 2.80 |
Authors | Studies |
---|---|
Cabral, WA; Collins, FS; Cubria, MB; DuBose, A; Erdos, MR; Kamalapathy, P; Karim, L; Masoudi, A; Nazarian, A; Oftadeh, R; Snyder, BD; Suarez, S | 1 |
Chen, S; Li, C; Li, H; Wang, R; Wang, Y; Yue, L | 1 |
Babenko, NA; Storozhenko, GV | 1 |
Babenko, NA; Hassouneh, LK; Timofiychuk, OA | 1 |
Charlesworth, G; Daroszewska, A; Prior, A; Ralston, SH; Rose, K; Rose, L; Sarsam, N; van 't Hof, RJ | 1 |
Casatti, CA; Cavazana, TP; de Almeida, JM; de Mello-Neto, JM; Dornelles, RCM; Ervolino, E; Garcia, VG; Issa, JPM; Nagata, MJH; Okamoto, R; Statkievicz, C; Theodoro, LH; Toro, LF | 1 |
Biguetti, CC; Constantino, DH; Custódio, IDC; De Oliva, AH; Duarte, MAH; Ervolino, E; Fakhouri, WD; Healy, K; Mahmoud, RH; Matsumoto, MA | 1 |
Jiang, K | 1 |
Brennan, MA; Gleeson, JP; McNamara, LM; O'Brien, FJ | 1 |
Bell, T; Bourque, WT; Daniels, T; Fetterly, CR; Harris, RL; Maurice, SB; Nelson, DR; Winwood, PJ | 1 |
Gruntmanis, U; Piper, PK | 1 |
Beck, FM; D'Atri, AM; Helm, NB; Huja, SS; Padala, S | 1 |
Boucher, A; Räkel, A; Ste-Marie, LG | 1 |
Anastasilakis, AD; Gkiomisi, A; Makras, P; Papatheodorou, A; Polyzos, SA; Savvides, M; Terpos, E | 1 |
2 review(s) available for zoledronic acid and Aging
Article | Year |
---|---|
Management of osteoporosis in the aging male: focus on zoledronic acid.
Topics: Aged; Aged, 80 and over; Aging; Bone Density Conservation Agents; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; United States; Zoledronic Acid | 2009 |
Role of zoledronic acid in the prevention and treatment of osteoporosis.
Topics: Age Factors; Aging; Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Injections, Intravenous; Osteoporosis; Osteoporosis, Postmenopausal; Risk Factors; Sex Factors; Zoledronic Acid | 2011 |
12 other study(ies) available for zoledronic acid and Aging
Article | Year |
---|---|
Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups.
Topics: Aging; Animals; Bone and Bones; Bone Density Conservation Agents; Cartilage; Disease Models, Animal; Femur; Glycosaminoglycans; Joints; Lamin Type A; Mice; Mice, Transgenic; Mutation; Osteoarthritis; Phenotype; Piperidines; Pravastatin; Progeria; Protein Processing, Post-Translational; Pyridines; X-Ray Microtomography; Zoledronic Acid | 2020 |
Effects of rosuvastatin and zoledronic acid in combination on the recovery of senile osteoporotic vertebral compression fracture following percutaneous vertebroplasty.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Bone Density; Case-Control Studies; Drug Therapy, Combination; Female; Fractures, Compression; Functional Status; Humans; Male; Middle Aged; Osteoporotic Fractures; Pain Management; Pain, Postoperative; Recurrence; Retrospective Studies; Rosuvastatin Calcium; Spinal Fractures; Treatment Outcome; Vertebroplasty; Zoledronic Acid | 2020 |
[Role of ceramide in reduction of the cardiolipin content in the heart during aging].
Topics: Age Factors; Aging; Animals; Cardiolipins; Ceramides; Diphosphonates; Doxorubicin; Heart; Imidazoles; Imipramine; Male; Myocardium; Phosphatidic Acids; Rats; Rats, Wistar; Sphingomyelin Phosphodiesterase; Topoisomerase II Inhibitors; Zoledronic Acid | 2017 |
Acid sphingomyelinase inhibitors, imipramine and zoledronic acid, increase skeletal muscle tissue sensitivity to insulin action at old age.
Topics: Aging; Animals; Ceramides; Diphosphonates; Imidazoles; Imipramine; Insulin; Male; Muscle, Skeletal; Rats; Rats, Wistar; Sphingomyelin Phosphodiesterase; Zoledronic Acid | 2018 |
Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62
Topics: Aging; Animals; Bone and Bones; Bone Resorption; Calcification, Physiologic; Disease Models, Animal; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Organ Size; Osteitis Deformans; Osteoclasts; Phenotype; Sequestosome-1 Protein; Zoledronic Acid | 2018 |
Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate.
Topics: Aging; Alveolar Process; Animals; Anti-Infective Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Collagen; Female; Interleukin-1beta; Interleukin-6; Mouth Mucosa; Osteogenesis; Photochemotherapy; Rats, Wistar; Tartrate-Resistant Acid Phosphatase; Tooth Extraction; Tumor Necrosis Factor-alpha; Wound Healing; Zoledronic Acid | 2019 |
Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: Microtomographic, histological and immunohistochemical characterization.
Topics: Aging; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Calcification, Physiologic; Collagen; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Female; Mice; Tooth Extraction; Transforming Growth Factor beta; X-Ray Microtomography; Zoledronic Acid | 2019 |
Drug development for progeria yields insights into normal aging.
Topics: Aging; Child; Clinical Trials as Topic; Diphosphonates; Drug Discovery; Humans; Imidazoles; Lamin Type A; Mutation; Piperidines; Pravastatin; Progeria; Pyridines; Time Factors; Zoledronic Acid | 2013 |
Effects of ageing, prolonged estrogen deficiency and zoledronate on bone tissue mineral distribution.
Topics: Aging; Animals; Bone Density; Bone Density Conservation Agents; Calcification, Physiologic; Diphosphonates; Estrogens; Femur; Imidazoles; Sheep; Time Factors; Zoledronic Acid | 2014 |
Tibial bone versican content decreases with zoledronate treatment in adult mice.
Topics: Aggrecans; Aging; Animals; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Female; Imidazoles; Mice, Inbred C57BL; Tibia; Versicans; Zoledronic Acid | 2014 |
Short-term zoledronic acid reduces trabecular bone remodeling in dogs.
Topics: Aging; Animals; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Dogs; Imidazoles; Lumbar Vertebrae; Male; Mandibular Condyle; Zoledronic Acid | 2010 |
Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment.
Topics: Activins; Age Factors; Aged; Aging; Biomarkers; Bone Density; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Female; Femur Neck; Humans; Imidazoles; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Zoledronic Acid | 2013 |